Revvity Inc. (RVTY) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Revvity, Inc. provides health sciences solutions, technologies, and services.

Total Cash From Operating Activities Chart for Revvity Inc.

Revvity Inc. (RVTY) operating cash flow for FY2025 was USD 581.8M, a -7.4% change from FY2024. Revvity Inc.'s operating cash flow grew from USD 52.4M in 1989 to USD 581.8M in 2025 (1010.3% over 36 years). Operating cash flow compound annual growth rate: 5-year CAGR of -8.2%, 10-year CAGR of 7.3%, 20-year CAGR of 5.3%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$12.74B
Implied Share Price
$114.24
Enterprise Value
$14.92B
Revenue (TTM)
$2.91B
EBITDA
$866.87M
Profit Margin
8.16%
Trailing P/E
55.19
Forward P/E
21.28
Price/Book (MRQ)
1.73
Price/Sales (TTM)
4.38
EV/EBITDA
19.30
EV/Revenue
5.14
Dividend Yield
0.12%
Book Value
$64.76
Free Cash Flow (FY2025)
$508.25M
Free Cash Flow Yield
3.99%

Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.